publication date: Jul. 24, 2015

FDA & NCI Create Unique Jobs Combining Regulatory Science with Clinical Expertise


NCI and FDA are recruiting three medical oncologists who would divide their time between clinical and regulatory duties—half at the FDA Office of Oncology and Hematology Products, and half at the NCI Center for Cancer Research.

These clinician-scientists would serve as associate directors for clinical research at the OHOP, and as independent, tenure-track principal investigators at the CCR.

This unique opportunity could not exist outside of government, OHOP Director Richard Pazdur said at a joint meeting of the NCI Board of Scientific Advisors and the National Cancer Advisory Board June 24.

“We want to create a unique position in the government that you can’t get on the outside. Hence, we’ve had these discussions on a joint position,” Pazdur said. “For instance, they can create and run a clinical trial at NCI’s CCR and then do the review work at the FDA.”

The unique job provides a way for FDA and NCI to recruit skilled oncologists who would otherwise command higher salaries in the private sector.

“One of the difficulties I’ve had in recruiting oncologists in government is attracting them to mid-career level positions,” Pazdur said. “When it comes to attracting very good physicians at the mid-level, we come across salary issues and conflicts with consulting agreements that government employees would potentially have.

“We designated three positions. These are FDA positions that I have dedicated … Continue reading 41-29 FDA & NCI Create Unique Jobs Combining Regulatory Science with Clinical Expertise

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.